ARTICLE | Clinical News
Rilpivirine regulatory update
August 2, 2010 7:00 AM UTC
Johnson & Johnson's Tibotec Pharmaceuticals Ltd. unit submitted an NDA to FDA for rilpivirine for use with other antiretrovirals in treatment-naive patients with HIV-1. TMC278 is a diarylpyrimidine no...